The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems
The COVID-19 pandemic has significantly accelerated progress in RNA-based therapeutics, particularly through the successful development and global rollout of mRNA vaccines. This review delves into the transformative impact of the pandemic on RNA therapeutics, with a strong focus on lipid nanoparticl...
Saved in:
| Main Authors: | Nargish Parvin, Tapas K. Mandal, Sang-Woo Joo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/16/11/1366 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery
by: Md. Anamul Haque, et al.
Published: (2024-12-01) -
Endo/Lysosomal-Escapable Lipid Nanoparticle Platforms for Enhancing mRNA Delivery in Cancer Therapy
by: Jiapeng Wang, et al.
Published: (2025-06-01) -
mRNA vaccine designs for optimal adjuvanticity and delivery
by: Yuki Mochida, et al.
Published: (2024-12-01) -
Exploring the potential of saponins as adjuvants in lipid-nanoparticle-based mRNA vaccines
by: Yulia Eygeris, et al.
Published: (2025-06-01) -
Deconvolution of cargo delivery and immunogenicity following intranasal delivery of mRNA lipid nanoparticle vaccines
by: Mai N. Vu, et al.
Published: (2025-06-01)